<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Osage University Partners - Medium]]></title>
        <description><![CDATA[We’re a VC fund with a singular focus on university startups. These are our thoughts on academic spinouts, technology transfer, and venture investing. - Medium]]></description>
        <link>https://medium.com/osage-university-partners?source=rss----a86acede77e---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>Osage University Partners - Medium</title>
            <link>https://medium.com/osage-university-partners?source=rss----a86acede77e---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 23:32:12 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/osage-university-partners" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Proof of Concept Funds: Boosting The Potential of University Technology]]></title>
            <link>https://medium.com/osage-university-partners/proof-of-concept-funds-boosting-the-potential-of-university-technology-b7663878a325?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/b7663878a325</guid>
            <category><![CDATA[fund]]></category>
            <category><![CDATA[tech-transfer]]></category>
            <category><![CDATA[proof-of-concept]]></category>
            <category><![CDATA[university]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[Jaimie Testai]]></dc:creator>
            <pubDate>Tue, 30 Nov 2021 14:43:03 GMT</pubDate>
            <atom:updated>2021-11-30T14:43:03.638Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/877/1*HN2fn2sUADsN-2kGMjZ61A.jpeg" /></figure><p>The <a href="https://oup.vc/insights/traversing-the-valley-of-innovation-death/">Valley of Innovation Death</a> has been well documented and is a continuing issue for transitioning basic university research into products that will improve lives. One way that universities and academic research centers are addressing this issue is through proof of concept (POC) funding. POC funds are typically grants that help “de-risk” a technology — helping a technology meet milestones that will increase its potential to be licensed to an existing company or enable the formation of a startup. These milestones can be prototypes, additional data, or other discoveries that will help demonstrate the validity of a technology. POC funds can also identify a technological weakness that is inhibiting further product development.</p><h4><strong>How are POC funds financed and managed?</strong></h4><p>There are similarities and differences between POC funds across academic institutions.</p><ul><li>Usually, universities and academic research centers fund and facilitate their own POC programs. Some funds, such as the <a href="https://innovationcenter.msu.edu/tech-transfer-commercialization/programs-and-resources/advance-grant-proof-of-concept-fund/">MSU ADVANCE GRANT Proof-of-Concept Fund</a> and <a href="https://ventures.jhu.edu/funding/translational-funding/johns-hopkins-university-grant-programs/">JHU’s various POC funds</a> are funded through partnerships with government, corporations, philanthropists, and other non-profit entities</li><li>POC grants are typically between $50-$150K per project with multiple projects being funded each year. This funding amount finances the experiments needed to meet specific milestones to advance the technology for commercialization.</li><li>Most funds utilize an external advisory board to review the applications and determine which grants will be funded. These advisory boards are typically comprised of individuals with industry, venture capital, or entrepreneurial experience who can help identify the next steps needed for the technology to be commercialized.</li></ul><h4><strong>What else can POC programs offer participants?</strong></h4><p>These POC programs are not just about the funding. Aligning with a university’s educational mission, they offer various training components that help faculty and students understand the commercialization process and what is needed to take their technology across the Valley of Innovation Death. <a href="https://www.udel.edu/research-innovation/horn/venture-support/blue-hen-poc/">University of Delaware Blue Hen POC Fund</a>, <a href="https://research.ucdavis.edu/offices/vc/stair/">UC Davis Venture Catalyst Programs</a>, and <a href="https://www.colorado.edu/venturepartners/lab-venture-challenge">UC Boulder Lab Venture Challenge</a> offer structured entrepreneurial training, while <a href="https://www.ucdenver.edu/sites/spark">University of Colorado Anschutz Medical Campus SPARK I REACH Awards</a>, which is modeled after the SPARK program at Stanford, provides weekly specific education seminars for program participants. <a href="https://ocr.yale.edu/BlavatnikFellowship">Yale Blavatnik Fellowship</a>s allow for scientists to develop entrepreneurship skills while creating life science startups, and <a href="https://newcures.northwestern.edu/">Northwestern NewCures</a> helps faculty develop a pitch deck for their technologies. <a href="https://research.rutgers.edu/techadvance/senior-fellowship">Rutgers TechAdvance</a> provides a Senior TechAdvance Fellowship which educates graduate students about technology commercialization. <a href="https://tdg.ucla.edu/UCLA-innovation-fund">UCLA Innovation Fund</a>, <a href="https://www.warf.org/warf-accelerator/">WARF Accelerator</a>, <a href="https://innovation.uic.edu/uic-innovation-fund/proof-of-concept-awards-program/">UIC Proof of Concept Award</a>, and UC Boulder Lab Venture Challenge also utilize pitch days to highlight their technologies as well as teach participating teams vital communication skills.</p><p>Other funds provide additional support to their awardees to aid their technology commercialization. Funds such as <a href="https://ip.mountsinai.org/about-i3-accelerator/">Mount Sinai i3 Accelerator</a> and Northwestern NewCures support projects requiring services from outside third-party organizations, such as CROs. UCLA Innovation Fund provides project management services while <a href="https://otd.harvard.edu/accelerators/blavatnik-biomedical-accelerator/for-faculty/">Harvard Blavatnik Biomedical Accelerator</a>, University of Colorado Anschutz Medical Campus SPARK Awards, and the WARF Accelerator all have a pool of mentors that acts as a hands-on advisory team to the faculty. These are just a few examples to summarize the tremendous number of services POC funds provide their faculty and students.</p><h4><strong>What impact do POC funds have?</strong></h4><p>These funds have a direct impact on the entrepreneurial and economic development efforts of the university. Many of the funded projects lead to new startups being launched or technology licensed to existing companies. Additionally, the funding and support from POC programs help attract follow-on funding either as additional grants such as the STTR/SBIR federal funding or venture funding for a startup. When a local startup is formed based on these technologies, that could lead to job creation in the local or state ecosystem. Here is a list of some universities that highlight their POC fund’s impact:</p><ul><li><a href="https://otm.illinois.edu/IPOC">UIUC IPOC Fund</a></li><li><a href="https://research.ncsu.edu/commercialization/chancellors-innovation-fund/">NCSU Chancellor’s Innovation Fund</a></li><li><a href="https://keenan.osu.edu/accelerator-awards">OSU Accelerator Awards</a></li><li><a href="https://lvg.virginia.edu/innovators/uva-proof-of-concept-programs">UVA Proof of Concept Programs</a></li><li>Harvard Blavatnik Biomedical Accelerator</li><li>UC Davis Venture Catalyst Programs</li><li>UIC Proof of Concept Award</li><li>UC Boulder Lab Venture Challenge</li></ul><p>Additionally, POC funds have been leveraged during this unprecedented time to help advance technologies in the fight against COVID-19. Some examples are</p><ul><li><a href="https://engineering.virginia.edu/research/centers-institutes/coulter-translational-research-partnership/projects">UVA Coulter Translational Research Partnership</a></li><li><a href="https://research.rutgers.edu/news/rutgers-researchers-receive-award-develop-rapid-sensor-detect-covid-19-and-other-infectious">Rutgers HealthAdvance</a></li><li>MSU ADVANCE GRANT</li></ul><p>Some universities even created separate POC funds for COVID like <a href="https://blogs.ohsu.edu/researchnews/2020/04/06/octri-and-onprc-announce-covid-19-funding-opportunities/">OHSU</a>.</p><p>POC funds are a tool in the arsenal to address the Valley of Innovation Death for university technologies. These funds provide critical funding at a time in a technology’s lifeline when there are few other sources. These funds are not just about the money — they educate faculty and students on how to further develop their technologies for the next commercialization milestone while also providing services to help them reach those inflection points. These funds continue to grow and optimize their programs and are a part of university technology success stories.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b7663878a325" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/proof-of-concept-funds-boosting-the-potential-of-university-technology-b7663878a325">Proof of Concept Funds: Boosting The Potential of University Technology</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Angel and Accelerator Funding: Continuing the Conversation]]></title>
            <link>https://medium.com/osage-university-partners/angel-and-accelerator-funding-continuing-the-conversation-b29fc7f34b11?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/b29fc7f34b11</guid>
            <category><![CDATA[angel-investors]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[accelerator]]></category>
            <category><![CDATA[startup-funding]]></category>
            <category><![CDATA[accelerator-program]]></category>
            <dc:creator><![CDATA[Jaimie Testai]]></dc:creator>
            <pubDate>Tue, 04 May 2021 17:58:43 GMT</pubDate>
            <atom:updated>2021-05-04T21:12:33.587Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*OLZiP4cSbDyyZP4nnh8ZoQ.png" /></figure><p><em>In late 2020, OUP hosted </em><a href="https://www.youtube.com/watch?v=VKYWnCt7sgE&amp;t=233s"><em>a webinar</em></a><em> on Angel and Accelerator Funding for University Startups. We reconnected with two of the panelists, Ashok Kamal, Executive Director of Tech Coast Angels, and Jun Axup, Chief Science Officer and Partner of IndieBio, to continue the conversation about angel and accelerator funding in addition to answering some follow-up participant questions. The panelists’ statements below have been edited for clarity and length.</em></p><h4><strong>What do you see as the top three skills and/or characteristics a scientist needs to become an entrepreneur?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> The top skill for me is what people call the “<a href="https://www.forbes.com/sites/forbescoachescouncil/2021/01/19/why-entrepreneurs-must-develop-a-growth-mindset-for-their-businesses/?sh=7fcce99f2ceb">growth mindset</a>.” The second skill is communication. As scientists we love to geek out about our science, but that can be more detail than needed. Scientists need to understand who they are talking to and be able to speak to all levels. The way that you talk to a corporate partner or a resource vendor is going to be different than talking to investors. The third skill is not being afraid to hustle and knock-on people’s doors. Always be curious.</p><h4><strong>What does IndieBio do to help develop scientists to become entrepreneurs?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> Our program focuses on 5 pillars: science, business, leadership, fundraising, and communication. The first and most important goal is to work towards proving or derisking the novel technology. But technology is not enough — the technology must be turned into a product that provides value to customers. Founders need to understand who their customers are and how to reach them in a sustainable business model. Then, as the company begins to grow, we help these founders become leaders, both in their fields and in establishing company culture. Lastly, we teach the founders how to fundraise by effectively communicating their story.</p><h4><strong>How does Tech Coast Angels (TCA) attract companies to pitch? Do you have to take this step, or do companies reach out?</strong></h4><p><strong><em>Ashok</em></strong><em>:</em> At the end of the day, a large percentage of our investments are direct referrals, but we have invested in companies that have cold contacted. When a company is referred, their process is often accelerated because there may be context to the relationship. If the company is coming in cold, you need to take the time to get to know them from scratch. At the end of the day, it is all about the companies’ traction, credibility, and performance. If a referral comes in that does not meet this criteria, it does not matter if you find out that criteria faster — you still are not going to make the investment.</p><h4><strong>How often are members of TCA sitting on boards or serving as advisors to the startups they invest in?</strong></h4><p><strong><em>Ashok</em></strong><em>:</em> The majority of our investments have members who are either voting board members, board observers, formal advisors or at least, mentors to the company. It varies across companies. If we feel there are individuals in the companies’ orbit that are a better fit to be board members or advisors, we always encourage the company to build the best independent board that they can. Only when it is value additive for TCA members to take on those roles, we certainly welcome those opportunities.</p><h4><strong>What do good pre-seed and seed investors do for the company?</strong></h4><p><strong><em>Ashok</em></strong><em>:</em> They put a meaningful amount of money into the company. That is what you do first and foremost for startups in order to be a good seed stage investor. If that is a given, it is also helpful to be available in advisory roles, aid with sourcing talent, and assist in answering questions that come up through the course of the startup’s operations. The other major function of earlier stage investors is helping to raise the next round of financing if that is the capital strategy for the company.</p><h4><strong>What are some of the advantages of working with an accelerator?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> The biggest advantage is the network of founders and mentors. You are around twelve other companies every day, so you get to see their successes and trials and learn from each other. An analogy I like to use is getting your PhD. In a PhD program, you have this nebulous five to seven years where it is unknown whether you will be able to publish, but the structure around the program has de-mystified it. You get to interact with other students, mentors, and committee members. Going to an accelerator is like that. Every founder is on a similar journey and going into untapped territory, so we want to help guide founders to not make the simple mistakes. Our mentors and alumni network share their learnings and resources.</p><h4><strong>What do you see as the size differences for pre-seed and seed rounds in different industry areas?</strong></h4><p><strong><em>Ashok</em></strong><em>:</em> We primarily invest in what most people would call Seed, Seed+, and even Series A companies, but not as many pre-seed companies. The big reason for that is there is an entire stratum of the startup ecosystem that focuses on pre-seed, pre-revenue, pre-launch companies which help startups develop those initial KPIs to then go and raise more institutional seed funds from groups like TCA. In terms of the dollar difference, we focus on approximately $500K investments. A lot of pre-seed companies are raising approximately $50–100K.</p><h4><strong>Any tips on approaching and pitching to angels and accelerators?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> There are countless problems of the world. Some are obvious, like climate change, and others not so much. We like to see teams that have a deep understanding of the problem they are trying to solve and have novel technology to address it. Applicants need to articulate the technological differences that allow them to solve this problem and align it with a business case.</p><p><strong><em>Ashok</em></strong><em>:</em> The amazing characteristic of academic startups is that they are grounded in novel, disruptive research that is sometimes years in the making at the university level. The downside is the gap between the commercialization opportunity and the science. The more that an academic spinout can demonstrate real market demand and sales capacity, that is what will differentiate them among their peers. In pitching, you need to connect those mental dots into a line that investors can see and understand how this company is going to eventually make money.</p><h4><strong>Can you share any thoughts on how entrepreneurs can find the right investors/accelerator that matches their company?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> Start by finding similar companies in your sector and then figure out who invested in them. Make sure you do not go to the VC that invested in your direct competitor, because usually VC firms will not invest in two companies that are direct competitors. You can start finding this information on Crunchbase and using the internet to investigate what VC firms are interested in your field. We also recommend talking to other founders who have worked with those accelerators/investors.</p><p><strong><em>Ashok</em></strong><em>:</em> A good starting point is an association for accelerators called the Global Accelerator Network (GAN). They have a searchable database of programs that span geographies, verticals, and stages.</p><h4><strong>What are your groups doing to increase diversity among startup founders, as well as your startup ecosystems overall?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> We highly value and celebrate diversity, because it leads to more creativity and addresses problems at the global scale. At least 40% of our companies have one female founder, and our founders represent over 37 countries. We are always looking to increase those numbers. Our founders also bring this ethos into growing their teams and being role models in their home ecosystems.</p><p><strong><em>Ashok</em></strong><em>:</em> Diversity is a competitive advantage at this point for the investors that recognize there are greater opportunities if you are able to see the world through a diverse lens. Research is clear that investors tend to invest in people that they can see themselves in. With that being the case, it is critical that the membership at a venture firm is representative of the startups that you trying to invest in. Therefore, we focus largely on increasing the diversity within the TCA membership. We also try to have a culture that is inclusive to everyone beyond just the membership. I think if you are able to mix that structure with a culture that is proactive, welcoming, and excited about diversity, the results start to show.</p><p><strong>What are some resources and methods for academic founders for their first pre-money valuation?</strong></p><p><strong><em>Jun</em></strong><em>:</em> Ultimately, you should not be so focused on the numerical value but understand what you can deliver in ~18 months for the next round. You need to find the Goldilocks’ amount. If you end up valuing your company way too high and with too much money, it could be harder to get to your Series A or Series B, because investors will expect you to accomplish a lot more. If it is not enough money, you cannot make your goals or have to raise a down round. A good guide is to budget out what you will need as realistically as you can and then add 50% for buffer.</p><p><strong><em>Ashok</em></strong><em>:</em> Valuation is part art, part science. At the early stage, it is more art than science. Comparables are a good way to triangulate into some sort of enterprise value. You can look at companies that are in a similar space. It may be difficult, because very novel technologies often do not have apple-to-apple comparables. You can try to find companies that are farther along and hope that investors can extrapolate from what your company is doing to what three other companies with a known value are. At the end of the day, valuation is a market function. If you really want a simple answer, the value of your company is what an investor is willing to pay you for it.</p><h4><strong>Have angels and accelerators shifted their focus or timelines under the cloud of COVID-19? Has our new virtual world helped your programs?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> The virtual world has changed the way we run our program and our day-to-day work. We definitely suffer from not seeing people in person and communicating more frequently, but the program itself translated well into the virtual setting. The back-to-back Zoom calls are more efficient and convenient to meet with people globally but can also be draining. We have decreased the formal aspects of our program to make sure people don’t get Zoom fatigue and can have more focus time. We’ve also shifted our communication training to be reflective of the Zoom world.</p><p><strong><em>Ashok</em></strong><em>:</em> The benefits have been more engagement from members, an equal amount of investment activity to our prior record levels and being able to meet with companies in a wider geographic scope.</p><p>In general, the benefits of virtual business are clear in terms of the time, convenience, and cost that can be saved. To not acknowledge that would be like when dating went online to websites and apps, people who stuck to their philosophy of meeting people at bars or birthday parties were limiting their prospects. That principle will apply to investors too. If you are limiting yourself to companies that you can meet in person right off the bat, you may be missing the investing love of your life who happens to be in Wisconsin. We want to be casting a large net, but we also look forward to building relationships in person as well.</p><h4><strong>Do you actively search for companies not in funding “hot spots”, especially now during the pandemic when meetings/programs are virtual? Have you funded companies outside the major tech hubs?</strong></h4><p><strong><em>Jun</em></strong><em>:</em> Yes, we have companies from all areas of the US and internationally. There is amazing science coming out of institutions all over, including non-hot spots. We want to see the creation of new hot spots, so we give talks about entrepreneurship at various universities to seed the idea to their graduate students. We’ve also seen that when our alumni finish our program, they take those learnings to strengthen entrepreneurship in those ecosystems. Scientists often don’t seem themselves founding a company, so as there are more and more role models, I believe the idea will become a viable career option for all graduate students.</p><p><strong><em>Ashok</em></strong><em>:</em> Yes, the challenge becomes how do we find those other companies or how do they find us? The onus needs to be on the company to find the investors that are not in their ecosystem. It should not be a buckshot approach. The companies themselves have to be more mindful and deliberate in researching and reaching out to investors if they are not finding the support in their local ecosystem. The post-COVID world should make it easier for you to bridge the gap geographically that may have limited your perspective or the receptiveness of the investors outside of town.</p><p><strong><em>We would like to thank Jun and Ashok for taking additional time out of their busy schedules to be interviewed for this piece. If you would like to connect with Jun or Ashok, they can be contacted at </em></strong><a href="/service/mailto:jun.axup@sosv.com"><strong>jun.axup@sosv.com</strong></a><strong> and </strong><a href="/service/mailto:ashok@techcoastangels.com"><strong>ashok@techcoastangels.com</strong></a><strong> respectively.</strong></p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2FVKYWnCt7sgE%3Fstart%3D233&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DVKYWnCt7sgE&amp;image=http%3A%2F%2Fi.ytimg.com%2Fvi%2FVKYWnCt7sgE%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/be033640005e1db2f18c0273fdd6b111/href">https://medium.com/media/be033640005e1db2f18c0273fdd6b111/href</a></iframe><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b29fc7f34b11" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/angel-and-accelerator-funding-continuing-the-conversation-b29fc7f34b11">Angel and Accelerator Funding: Continuing the Conversation</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[TTO Strategic Communication Tactics with VCs]]></title>
            <link>https://medium.com/osage-university-partners/outbound-tto-communication-tactics-with-vcs-521abe10568b?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/521abe10568b</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[technology-transfer]]></category>
            <category><![CDATA[vc]]></category>
            <category><![CDATA[tech-transfer]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Natasha Azar]]></dc:creator>
            <pubDate>Thu, 03 Dec 2020 19:43:25 GMT</pubDate>
            <atom:updated>2020-12-07T15:53:18.225Z</atom:updated>
            <content:encoded><![CDATA[<p>As a VC firm partnered with over 100 universities, we get the question from Tech Transfer Offices (TTOs) all the time — how can we best communicate with VCs?</p><p>While investors have directed more attention to universities for deal flow in recent years (see bar graph below), most VCs don’t have a singular focus on startups commercializing university research and settle for letting the startups come in via normal channels, e.g. introductions from other VCs, investor conferences, pitching events, and the news. And for institutions that aren’t in the Boston biotech hub, or the Bay area, or New York City, or even other major coastal cities — rising above the noise level of their peers to attract attention from top-tier venture capital, angel, and strategic investors can be a challenge.</p><p>So what can TTOs do to attract investors to their university’s startup opportunities? Here are some tips from OUP, with help from <a href="https://techtransfer.umich.edu/team/mike-psarouthakis/">Mike Psarouthakis</a>, Venture Center Director at the University of Michigan and <a href="https://olv.duke.edu/team_members/rob-hallford/">Rob Hallford</a>, Director of New Ventures at Duke University, both of whom recently participated in our webinar in May 2020 entitled ‘<a href="https://www.youtube.com/watch?v=MAcN6jjonqQ">Cultivating Relationships with Investors at Your University</a>.’</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*J8hd-t4A47YbEx_C8z-gAg.png" /><figcaption><strong><em>Source: OUP Proprietary Data &amp; Pitchbook. </em></strong>To provide context for the discussion, let’s look at funding activity in university startups over the past 5 years. While there was a gradual increase in the total capital raised by university spinouts from 2015–2017, there was a 63% percent increase between 2017–2018 and a 51% jump from 2018 to 2019. We’ll examine later which firms have been top funders of university spinouts to shed light on who our partner TTOs should have on their VC radar.</figcaption></figure><h3><strong>Curate a List of Investor Contacts</strong></h3><p>Start with your personal networks. For TTOs that run a Mentor-in-Residence (MIR) program, these individuals are invaluable in introducing investors to your university’s startups. Most MIRs have worked in venture capital or have worked with investors in some capacity.</p><p>Not all TTOs have an MIR or EIR network they can tap into. If your university has a Business school, request an introduction to their investor relationships. For Mike and Rob, attending investor-packed events such as JP Morgan, BIO, CES and SXSW Interactive to have one-on-one meetings with VCs and angels is key in building their own networks. Before the events, use your existing network of VCs to broker introductions to others as a way to proactively plan your time.</p><p>Another tactic Rob uses to curate his investor list is intentionally targeting Principals and non-partners at VC firms, in particular those in Boston and the Bay area. Junior VCs are more willing to visit a campus outside of a major city to start building relationships with faculty.</p><p>Mike develops relationships broadly, and actively uses Pitchbook and LinkedIn to seek out new investors to contact. In Pitchbook he looks at portfolio, capital available, interested sectors, prior co-investors, etc. Capturing this information prior to meeting with investors is valuable in understanding what they’re looking for and how they will engage with the university. LinkedIn is another great tool for uncovering alumni investors.</p><p>To get an idea of who invests in university spinouts, here is a list of the top 10 VCs investing in both the physical sciences and life sciences space.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/396/1*by2ysZwamZotunR2UMbLCQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/397/1*UbEdsZY1ocAQl2u9hFLtPA.png" /><figcaption><em>If you are an OUP academic partner, </em><a href="https://portal.oup.vc/page/topinvestors"><em>click here to be taken to our Partner Portal to view an extended list of investors</em></a><em>.</em></figcaption></figure><h3><strong>Investor Outreach Management</strong></h3><p>Michigan utilizes the UM Pipeline report — a spreadsheet created by the University of Michigan to organize their startup pipeline in a consumable format for investors. The pipeline report is sent out quarterly to approximately 500 VC firms, accredited angels, and strategic investors. To be on the list, investors have had at least a soft touch with the office. The 150–170 startup projects currently on the list are segmented into three buckets: early stage projects that are still a year or longer before launch, projects close to launching or those that recently turned into startups, and startups actively fundraising or who expect to be fundraising in the next 12–18 months.</p><p>For this last pool of companies, the spreadsheet provides a high overview of the company, the PIs involved, sector, stage, tech readiness level (TRL) and investment readiness level (IRL). Investors can contact these actively fundraising companies directly via the contact information included in the list. For Michigan, this process has opened the door to 6 deals that have closed, and to additional ongoing conversations. Mike uses this report as a tool to communicate the number and variety of opportunities to a large pool of investors at a high level. <em>If you are an academic partner of OUP’s, you can download a template of this document on our Partner Portal </em><a href="https://portal.oup.vc/page/new_ventures"><em>here</em></a><em>.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*BkatlrFmTrnGkoA2IjISOA.png" /><figcaption>A preview of the U-M pipeline report template. <strong>Please note: All information in the spreadsheet is fictional.</strong></figcaption></figure><p>Duke implements a phased approach for their startups, and there is a clear distinction between startups in the ‘refinement’ versus ‘venture development’ phases in their pipeline. This way, Rob’s team is showing VCs the projects that are ready and in a format VCs are used to hearing.</p><p>With new investors, it’s about understanding what their interests are and hand-picking a few technologies to give a flavor of the work Duke does. Keep in mind that for the most part, investors want to hear about new things.</p><h3><strong>When to Approach Investors</strong></h3><p>Like Duke, Michigan works closely with PIs and startup teams to make sure they are represented correctly to VCs. When deciding if a project is ‘VC-ready,’ Mike says it depends on the VC. There are early stage or pre-seed stage investors who are prepared to invest $200K into a company, and there are investors who aren’t interested unless they can invest $5M+ and the technology is further along. In this latter category of large VCs, most are still interesting in getting the startup on their radar early, but may be less responsive to setting up a meeting.</p><p>Where some VCs have a specific investment threshold, others have management team requirements before considering a deal. As a TTO, it’s important to <strong>know your investors</strong> before sending them deals. Some VCs will invest in a startup where there is only a technical founder in place and not an outside CEO, where others won’t consider an deal without a CEO in place.</p><p>At Duke, the New Ventures team keeps a handful of investors close to them. Before casting a wide net, Rob will reach out to a smaller ‘safe’ group of contacts to get initial feedback and avoid showing a large group of top-tier investors a project without enough data.</p><p>Deciding what is ‘VC-ready’ depends on current market trends, the industry, and the faculty member behind the project. What’s a hot area attracting VC attention? Who are the sought-after faculty? The worst that could happen is a VC turns the opportunity down because the story wasn’t told effectively.</p><p>TTOs have the added challenge of deciding whether to act as a ‘screener’ and send a small number of quality deals to VC contacts, versus sending everything in their pipeline. There are arguments for and against each of these methods. At OUP, we find it more effective when TTOs filter deals and send what they deem to be the most investable opportunities.</p><h3><strong>When a VC Wants to Interact with a Company</strong></h3><p>When a VC expresses interest in one of your university’s companies, provide them screening material in the form of a pitch deck where possible. If a presentable pitch deck isn’t available, have a succinct paragraph prepared to send that describes the team’s background, the technology, and market. Avoid sharing white papers or business plans with a potential investor — these will not articulate the startup’s story in an investor-friendly format.</p><p>As a TTO applying office resources to VC outreach efforts, it is tempting to insert oneself into the discussions or follow up with the VC for feedback and metrics tracking. However, in the early days of a new VC relationship, most investors would appreciate a low friction experience where they can communicate directly, and only, with the startup. At the end of the diligence process, a VC will let the company know their investment decision; don’t expect a VC to contact the TTO to provide the same feedback, if not only because some VCs may think of the startup and the TTO as a unified entity. As a relationship grows with an investor, the natural progression may lend itself to the TTO being more involved in the process.</p><p>On average, a large institutional VC is not going to find more than a few startups each year from your institution that perk their interest. The stage of most TTO-driven startups is earlier than VCs operate, so it may be a rare event that they want to connect. If they do, it could genuinely be for an investment, or it may be to get smarter on a space, or to start tracking a company for a more substantial round. It is also normal for these early VC interactions to be with associates and analysts from the firm, so do not expect partners to inquire about a company or join the first calls with a company.</p><h3><strong>Attracting Investors to Events</strong></h3><p>Investor-focused events are an effective way to shine a light on your startups and capture VC interest. TTOs should be encouraged to set up meetings when investors are on campus for events such as pitch competitions, showcase days, etc. Rob recommends also taking advantage of investor presence on campus to set up meetings with faculty who are earlier in their startup process.</p><p>Not all VCs are going to be willing to travel to campus. “But investors who do make the time to visit and provide good feedback to our startups are the ones who get first look at startup opportunities,” according to Rob. Relationship building with investors in a COVID world might prove easier with business travel still suspended for many. TTOs may have more success contacting VCs (especially junior VCs) and getting them to attend virtual events.</p><p>Duke’s Venture Days are invite-only. Limiting the audience and not allowing service providers makes the event just about investors and investable deals. Rob markets them directly by talking in person with investors while at JP Morgan and other events.</p><p>For UM, the launch of a regional investor event, the Midwest Growth Capital Symposium, has raised the profile for startup activity in the Midwest and brought non-regional alumni VCs to the state of Michigan. Regional investors benefit from this event too, as they can engage with non-regional VCs from the major tech hubs without having to travel.</p><h3><strong>Measuring Success of Your Investor Introductions</strong></h3><p>For Duke, it depends on feedback they receive from investors. The piece of feedback most often heard is that the technologies are very early. People who invest in university spinouts understand this reality, but there could be a long lag time between making an investor introduction and seeing a measurable outcome.</p><p>Re-engagement is a key metric for Mike. If a fund maintains contact with a startup, this is a quantifiable ‘success’ even if the fund doesn’t eventually invest. Similarly, if a fund makes an introduction to another investor, this is also named a success to the Venture Center Team. This means the pitch was compelling enough to put their reputation on the line to introduce to another investor connection.</p><p>In many ways, the VC-TTO relationship is similar to the relationship between two VCs. As the VC-TTO relationship grows and trust builds, so will the rate of communication between the two entities in a way that drives a strong flywheel for increased activity amongst the two groups.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=521abe10568b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/outbound-tto-communication-tactics-with-vcs-521abe10568b">TTO Strategic Communication Tactics with VCs</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[2019 Court Decisions: Implications for University Licensing]]></title>
            <link>https://medium.com/osage-university-partners/2019-court-decisions-2ceca196f4ee?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/2ceca196f4ee</guid>
            <category><![CDATA[licensing-agreement]]></category>
            <category><![CDATA[tech-transfer]]></category>
            <category><![CDATA[university]]></category>
            <category><![CDATA[licensing]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Lou Berneman]]></dc:creator>
            <pubDate>Wed, 07 Oct 2020 15:40:59 GMT</pubDate>
            <atom:updated>2020-10-07T15:43:07.337Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/250/1*diQHxLF6-FeszE4CGuQHoA.jpeg" /><figcaption>Russell E. Levine, JD, Kirkland &amp; Ellis</figcaption></figure><p>On September 2, 2020, <a href="https://www.kirkland.com/lawyers/l/levine-russell-e-pc">Russell E. Levine, JD, Kirkland &amp; Ellis</a>, presented an <a href="https://autm.net/">AUTM</a> webinar entitled “Top 10 Court Decisions of the Year That Affect Licensing.”</p><p>Russell, a past president of LES USA &amp; Canada, has been doing these “top 10” talks for many years at LES annual meetings. These talks are always a full house, must-see event at LES. As usual, Russell was well prepared and did a superb job for AUTM and its listeners. These “top 10” suggest that courts have recently decided that:</p><ul><li><strong>Standing matters — exclusive licensees need all substantial rights to litigate.</strong></li><li><strong>Licenses may include an implied license to continuation applications.</strong></li><li><strong>Arbitrators yield immense power.</strong></li><li><strong>Beware the scope of integration clauses.</strong></li></ul><p>For me, two overarching themes emerged from Russell’s webinar.</p><ol><li><strong>The more things change, the more they stay the same</strong>. This year’s “Top 10 Court Decisions of the Year That Affect Licensing” addresses issues that have faced universities<a href="#_ftn1">[1]</a> for decades.<a href="#_ftn2">[2]</a></li><li><strong>What we do and how we do it matters.</strong> University licensors have “the power of the pen.” In adjudicating disputes, judges and arbitrators will presume people structuring, valuing, negotiating, and drafting license agreements are qualified professionals with relevant expertise. Meaning, what the agreement says is what the agreement means and the people crafting licenses know (or should know) what they’re doing.</li></ol><p>But, herein lies the problem and challenge for university licensing. We know from experience that only a small percentage — perhaps, fewer than 10% — of university licenses will ever generate meaningful results — inventions enabling innovations that change the way people live, work, and play. And, even far fewer — perhaps as few as 1% — generate substantial licensing revenue. Except for the limited number of universities with “home run” licenses, university technology transfer is not a substantial revenue generator.<a href="#_ftn3">[3]</a> University technology transfer offices are conventionally limited in their resources, both financial and managerial and were so even before the Covid-19 pandemic. Thus, the dilemma: how do you allocate the paucity of time available from experienced licensing professionals to patent license negotiations with the greatest probability of success (however the institution defines and prioritizes success)?<a href="#_ftn4">[4]</a></p><p><strong>Direct implications for university licensing from Russell Levine’s 2020 AUTM Webinar: “Top 10 Court Decisions of the Year That Affect Licensing.”</strong></p><h4><strong>1) STANDING — ALL SUBSTANTIAL RIGHTS</strong></h4><p>Universities typically seek to retain rights to use the licensed patents for internal, non-commercial teaching and research purposes. Universities may also seek to approve licensees’ grant of sublicenses, restrict rights to enforce, limit licensees’ scope of rights to licensed patents, and more. Courts have held that standing to sue requires licenses to convey all substantial rights (including the right to enforce, sublicense, practice, etc.) patents being licensed. Courts have expressed different views on standing and all substantial rights: Can the licensee sue in its own name? Can the licensee sue only with the involvement of the patent owner? Can the licensee not sue? Standing and all substantial rights must be considered by university licensors to avoid becoming involved in licensees’ litigation of the licensed patents.</p><p><em>[Top 10 Case: Infernal Technology, LLC v. Sony Interactive Entertainment America, LLC, 2020 WL 305082 (E.D. Texas 2020)]</em></p><h4><strong>2) LICENSED PATENT RIGHTS ARE PRESUMED TO INCLUDE AN IMPLIED LICENSE TO CONTINUATION APPLICATIONS</strong></h4><p>Beware of this one! Courts have held that unless specified, licensees may have implied rights to continuation applications, including, perhaps, continuations describing improvements not claimed in licensed patent rights and those not discovered and reduced to practice with support from licensees. Specificity in the delineation of the scope of rights granted and not granted is required.</p><p><em>[Top 10 Case: Cheetah Omni LLC v. AT&amp;T Services, Inc., 949 F.3d 691, (Fed. Cir. 2020)]</em></p><h4><strong>3.) ARBITRATION (ALTERNATIVE DISPUTE RESOLUTION (ADR)</strong></h4><p>University licensors should carefully consider whether or not to use arbitration (and/or other alternative dispute resolution mechanisms). There can be advantages to ADR. Arbitrations can be faster than court disputes and timelines for resolution can be specified. Arbitrations can be less expensive. Discovery and depositions in arbitrations can be limited. The characteristics (expertise and experience) of arbitrators can be specified. That said, each license situation poses fact-specific issues to address in deciding whether or not to use ADR.</p><p>Parties to a license may designate which issues/license provisions are arbitrability and which are to be addressed by courts. Such delineation must be specific. If not specified, arbitrators have been deemed to have the right to determine arbitrability. That is, whether the issue falls within the scope of the arbitrator’s authority. Arbitrators will resolve questions regarding the scope of arbitration.</p><p>Rules of arbitration are set by the various arbitration organizations.<a href="#_ftn5">[5]</a> University licensees should review rules and procedures of these organizations before agreeing to ADR.</p><p>Courts are extremely deferential to arbitrators’ decisions and awards. It is difficult to challenge arbitrators’ decisions even if they have made factual errors.</p><p><em>[Top 10 Cases: Safran Electronics &amp; Defense SAS v iXblue SAS, 2019 WL 5250790 (2nd Cir. 2019); Seattle Genetics, Inc. v. Daiichi Sankyo Co., Ltd., Case №01–19–0004–0115 (AAA 2020); PNY Technologies, Inc. v. Netac Technology Co., Ltd., 2020 WL 1919160 (3rd Cir. 2020)]</em></p><h4><strong>4) INTEGRATION/ENTIRE AGREEMENT CLAUSES</strong></h4><p>Universities often enter into multiple agreements with the same licensee. Integration and entire agreement clauses should specify if other agreements between the parties are to be included or not in the license being negotiated. That is, institutions having multiple agreements with the same counter-party should specify if and which other agreements (e.g. sponsored research, settlements, other licenses) are to be included in the integration/entire agreement provision.</p><p><em>[Top 10 Case: Molon Motor and Coil Corporation v. Nidec Motor Corporation, 946 F.3d 1354, (Fed. Cir. 2020)]</em></p><p>Six of Russell’s “top 10” involve the issues above. Other cases addressed by Russell speak to courts’ enforcing definitions and termination provisions as stated.</p><h3>Footnotes</h3><p><a href="#_ftnref1"><em>[1]</em></a><em> Universities include other not-for-profit research institutions and organizations, including degree and non-degree granting institutions, medical schools and teaching hospitals, government laboratories, and the like.</em></p><p><a href="#_ftnref2"><em>[2]</em></a><em> I recall that “standing” and “arbitration” were issues in licenses I negotiated in the early 1980s.</em></p><p><a href="#_ftnref3"><em>[3]</em></a><em> Fewer than half of U.S. university technology transfer programs generate licensing revenues in excess of program operating costs and “only 16% are self-sustaining, bringing in enough income that, after distributions to inventors and for research, there are sufficient funds to cover the operating costs of the program.” How are U.S. Technology Transfer Offices Tasked and Motivated — Is It All About the Money? by Irene Abrams, Grace Leung, and Ashley Stevens. Research Management Review, Volume 17, Issue 1 Fall/Winter 2009. As I have written and said for decades, universities engage in technology transfer for five good reasons: 1. Bayh-Dole mandate; 2. Increase interactions with industry; 3. Promote economic development; 4. Support faculty and students; and 5. Generate licensing revenue.</em></p><p><a href="#_ftnref4"><em>[4]</em></a><em> I had a decade of personal experience with this dilemma during my decade as the managing director of the University of Pennsylvania tech transfer program.</em></p><p><a href="#_ftnref5"><em>[5]</em></a><em> American Arbitration Association, JAMS, International Chamber of Commerce, Chartered Institute of Arbitrators and others.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2ceca196f4ee" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/2019-court-decisions-2ceca196f4ee">2019 Court Decisions: Implications for University Licensing</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Equalize — 2020 and Beyond]]></title>
            <link>https://medium.com/osage-university-partners/equalize-2020-and-beyond-839cb22e32c8?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/839cb22e32c8</guid>
            <category><![CDATA[female-founders]]></category>
            <category><![CDATA[women]]></category>
            <category><![CDATA[equalize]]></category>
            <category><![CDATA[women-entrepreneurs]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Kirsten Leute]]></dc:creator>
            <pubDate>Thu, 06 Aug 2020 14:56:23 GMT</pubDate>
            <atom:updated>2020-08-07T13:57:59.286Z</atom:updated>
            <content:encoded><![CDATA[<h3>Equalize — 2020 and Beyond</h3><p><em>by Nichole Mercier, Kristen Otto, and Kirsten Leute</em></p><p>It’s been a few weeks since our <a href="https://equalize.wustl.edu/">Equalize 2020</a> event. All of those involved are still reflecting on the impact of the event, while excited to take the next steps in this journey. With this article, we wanted to articulate the need and history of Equalize 2020, the experiences of those involved, and our thoughts on where to take this effort next.</p><h4><strong>The why and what of Equalize</strong></h4><p>Equalize is the result of many conversations about how we can affect real change in the area of women researcher engagement in commercialization and entrepreneurship. Nichole Mercier had the vision for the event based on her experiences at Washington University in St. Louis, and she brought in supporters from around the United States to help with the effort. From discussions with those supporters, Equalize 2020 evolved into a 6-month mentorship program for 12 women-led startups from U.S. academic institutions, culminating in a pitch competition on June 25, 2020.</p><p>The statistics around actual participation in tech transfer and entrepreneurship highlight the obvious need for opportunities such as Equalize — those that actively invite women to the table, support their efforts throughout the entrepreneurship process, and carefully help to navigate the common barriers on the road to entrepreneurship. Women are 40% less likely to communicate their ideas to the tech transfer office. And, according to data from the USPTO, women only make up 12% of the inventor population. Further data from Osage University Partners (OUP) assessed their university startup portfolio to find that only 11% had a female founder.</p><p>At Washington University in St. Louis, that number is only 3–4%. But this is a staggering increase from zero in 2014– when the university started programming for women inventors. Early on, leaders recognized that to evoke real change, a national endeavor was the only option.</p><p>Leaders questioned whether researchers would be interested or even willing to participate, whether they’d invest their valuable and highly limited spare time on this extracurricular activity that brings no contribution toward tenure and promotion like another grant or publication would. Yet, Equalize 2020 received close to 60 applications from enthusiastic women across the country who submitted their early stage pitch decks. From those 60, 12 were chosen for this inaugural event to be mentored and pitch to an audience of investors, fellow entrepreneurs, business executives, university new ventures staff, and other stakeholders in the startup ecosystem.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*5Vmg-RLsfa14Px5hbjdf5w.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6hG635d0NCi07AMHeJCqKw.png" /></figure><p>Leading up to the pitch event, our <a href="https://equalize.wustl.edu/pitch/">presenters</a> had exceptional mentorship for 6 months. These mentors truly understood the barriers women face to engaging in entrepreneurship, but let’s take a moment to reflect on the adversity these teams faced in this acute moment — they managed through fully shutting down their research activities to then working on a full reopening. They managed through caring for children as daycares shut down, administering digital learning when schools closed, learning to treat patients under new regulations, and helping their own institutions define COVID responses. Despite these challenges, both mentors and participants formed trusted bonds with one another. Mentors selflessly opened their networks, individuals empathetically rescheduled meetings, and each team member put in more hours with one another than was expected. Equalize has been a game changer for participants who described having their first female mentor as someone who could challenge them to a higher business capacity or feeling starstruck by the incredible background yet totally down to earth nature of their “rock star” mentor.</p><h4><strong>Equalize 2020</strong></h4><p>As for the event itself, we shifted quickly from an in-person combination of workshops, panels, and pitching program to a completely virtual event comprised of an online keynote from Elizabeth Dougherty of the USPTO followed by 10-minute pitches from all 12 entrepreneurs. Instead of pitching before a live audience, as all of our applicants had originally intended, they had to be their own IT department, learning the ins and outs of the Zoom webinar platform prior to the event. From experience with prior Zoom events, we knew this would not go off without some hitches, but whenever those hit during our 5-hour event, the presenters, judges, and audience handled them with patience and grace.</p><p>Some of the feedback we received on the event:</p><blockquote><em>“It was amazing to see so many women and have them not be a novelty.”</em></blockquote><blockquote><em>“This was very a positive experience and really caused me to look deeply on where I need to make impact in my career.”</em></blockquote><blockquote><em>“All of the pitches were incredible. What a wonderful experience to hear from these awesome women academic entrepreneurs!”</em></blockquote><p>One part of the event that stood out for many audience members was the useful feedback from the judges in each of the cohorts. We were honored to have judges who are business and startup leaders in their respective disciplines:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9i3QPdRNp9KI_PXN84y4IQ.png" /></figure><p>The proudest moment of the event for us was each and every presentation that was given. Seeing how much these presenters had accomplished during a time of upheaval in all of their lives was impressive and heart-warming. We also know how difficult it was for both our audience and judges to choose winners — the results were very close!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*lITEZAeYMFjDpmtVoHOAfQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*AzyT44GXjCRRhcnDGreICQ.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*sjYaj7w_2oxZJCKzSsEorg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*hei7RIoLOY2TYcLkdw8cGA.png" /></figure><p>One of the benefits of going virtual was the broader impact of the event. People who perhaps could not have attended in person could join the event. Since the Equalize 2020 was conducted online, we were able to inexpensively record it and <a href="https://www.youtube.com/watch?v=pQBomfZYOfE&amp;t=711s">post the event on YouTube</a>.</p><p>A special shoutout to all of our sponsors who support efforts like Equalize that seek to diversify the innovation pool and increase the number of women entrepreneurs in America.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_mYLnJIu4Nn8XgZkDWq6ag.png" /></figure><h4><strong>The journey doesn’t end here</strong></h4><p>Equalize 2020’s journey began with the acknowledgement there was a missing piece in the university entrepreneurship system — <strong><em>a cross-university mentorship program and pitch platform for women academic entrepreneurs</em></strong>. The result of this missing piece: lost opportunities in translating science to products and transforming leading academics into leading company founders. We were truly blown away by the incredible number of applications we received for Equalize 2020, which were mostly scientific ideas. In addition, the feedback from our mentor-mentee pairings has been extremely positive. This is a scalable solution.</p><p>We know that the journey can’t stop after this one program. The need is real, as are the benefits of these programs and the connections they help make.</p><p>With Equalize 2020, we concentrated on startups in the life sciences arena. However, the disparities are even greater in other scientific fields, so next steps include programming for all STEM areas. Our initial concept was not just a mentoring and pitching program, but also workshops and networking possibilities for all people attending the in-person event. With the world in a virtual stance for now, we’re shifting to remote possibilities for these areas.</p><p>During the program, we asked those attending to let us know if they want to be involved going forward. We have been overwhelmed by the positive responses. If you are interested in joining us on the next part of our journey — as a mentor, a mentee, a brainstormer, a thought leader, a funder, an organizer — please contact us via email: equalize@wustl.edu.</p><p>When we started Equalize, we made a commitment to empower academic women entrepreneurs. It is important to recognize that many other underrepresented populations have felt the barriers to engaging in the space of innovation and entrepreneurship. As we look to our next steps on Equalize, one of our biggest considerations will be how we continue and expand this impact.</p><p>We plan to put out a call for our applications to our next round of cohorts in October of 2020. Keep an eye out for our announcements at equalize.wustl.edu. This isn’t just Equalize 2020 anymore — it’s Equalize.</p><p><em>To find out more about Equalize, click </em><a href="https://equalize.wustl.edu/"><em>here</em></a><em>.</em></p><p><em>To get involved with Equalize, please contact us at </em><a href="/service/mailto:equalize@wustl.edu"><em>equalize@wustl.edu</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=839cb22e32c8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/equalize-2020-and-beyond-839cb22e32c8">Equalize — 2020 and Beyond</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why work in tech transfer? The pandemic has illustrated why people do.]]></title>
            <link>https://medium.com/osage-university-partners/why-work-in-tech-transfer-the-pandemic-has-illustrated-why-people-do-4ab69140ce7e?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/4ab69140ce7e</guid>
            <category><![CDATA[pandemic]]></category>
            <category><![CDATA[university]]></category>
            <category><![CDATA[technology-transfer]]></category>
            <dc:creator><![CDATA[Kirsten Leute]]></dc:creator>
            <pubDate>Tue, 23 Jun 2020 20:41:35 GMT</pubDate>
            <atom:updated>2020-06-23T20:41:35.762Z</atom:updated>
            <content:encoded><![CDATA[<p>It’s hard to work, write, or think about anything without the context of COVID-19 these days. Living at the intersection of academic institutions and new ventures, I have daily insights into the plethora of programming at universities intended to advance scientific discoveries and see them translated into practice, especially through the activities of the technology transfer offices.</p><p>Working as a staff member at an academic institution does not tend to be glamorous. Hierarchy is an inherent trait of a university, and staff typically are not in the upper echelons of the pyramid. Those who do make it to a director level are often subject to the whims of the changes in the administration. One of the first questions I was asked by my colleagues when I started working at OUP was “Why is there so much turnover in technology transfer offices at universities?”</p><p>The fact of the matter is that people often change jobs in tech transfer, at least in the United States, although I have seen it in other countries as well. Thousands of people work in the industry across the world. Most of the tech transfer officers I know are working hard for minimal personal financial reward, although they do feel pride in the work they do. They do not share in the upside of the deals they negotiate. They don’t receive large yearly salary increases (and in times like these, there are no salary increases or in some cases there are even furloughs at the academic institutions). Service awards or recognition otherwise by their academic colleagues is rare. The upsides of jobs in industry become alluring.</p><p>Given the downsides I noted, the question has become even more relevant during the pandemic — why work in tech transfer? Because you are helping life-saving inventions cross one of the thresholds from labs to patients. Because you have a community that cares about what they do, cares for each other, cares that they make a positive impact. As a professional in the area, you learn about and shepherd along the best innovations scientists are creating — what may be the next industrial robot, the next search algorithm, the next pancreatic cancer diagnostic test, the next COVID-19 vaccine. Each day, you work with passionate individuals whose main goal is to see their baby grow up and do something that makes a difference, whether it transforms the lives of a small population, impacts the globe, or advances our exploration of the universe. The pervasive mindset is “How can I help make a solution a reality?”</p><p>One need only look at the many examples from universities to see how this community performs and cares, as highlighted in this <a href="https://www.pbs.org/newshour/science/how-universities-are-developing-covid-19-solutions-in-real-time">PBS NewsHour article</a> in April. Universities stepped up to the plate early in the pandemic to design and mass produce <strong>personal protective equipment</strong> (see designs and efforts from <a href="https://techventures.columbia.edu/face-shield-designs-columbia-engineers">Columbia</a>, <a href="https://techcrunch.com/2020/03/27/nyu-makes-face-shield-design-for-healthcare-workers-that-can-be-built-in-under-a-minute-available-to-all/?guccounter=1&amp;guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&amp;guce_referrer_sig=AQAAAGIKUlewQNntYZreZU1sZKO387XvqDwpkG78cpHIeKpmNRX1uw5_pUCP7FBAewYxf_KFLwLHlqyPsTo-gaZK5KVyVWAF-AbeihrHA9hspuicQlIH3F5NIdR7_VfXOPnW4COVaOso61HWgJnngH3Cd7LXhnGgPmafmeqkdvvbXRqo">NYU</a>, <a href="http://www.umass.edu/ials/covid19/umass-face-shield">UMass</a> and <a href="https://temple-news.com/temple-ramps-up-production-of-protective-face-shields/">Temple</a>, just to cite a few) and the tech transfer offices shepherded many of these solutions to reality, making their way to medical professionals. To help ensure any solutions did not run afoul of legal complications, the tech transfer offices developed <strong>simple license guidelines</strong> (<a href="https://autm.net/about-tech-transfer/covid19/covid-19-licensing-guidelines">https://autm.net/about-tech-transfer/covid19/covid-19-licensing-guidelines</a> and <a href="https://otl.stanford.edu/covid-19-technology-access-framework).">https://otl.stanford.edu/covid-19-technology-access-framework).</a> Since the early days of the pandemic, the technology transfer offices have received numerous invention disclosures from researchers eager to help. There are many examples of <strong>new tests, treatments</strong>, <strong>and vaccines</strong> to address the pandemic from these academic institutions (link here to potential <a href="https://www.unc.edu/posts/2020/04/06/carolina-researchers-key-role-in-the-development-of-new-covid-19-treatment/">UNC</a> Chapel Hill therapy, <a href="http://news.mit.edu/2020/covid-19-diagnostic-test-prevention-0312">MIT</a> diagnostic, <a href="https://spectrumnews1.com/wi/madison/news/2020/04/07/uw-madison-scientists-developing-coronavirus-vaccine">University of Wisconsin-Madison</a> vaccine and <a href="https://www.sciencealert.com/oxford-university-has-just-launched-a-human-trial-of-a-potential-covid-19-vaccine">Oxford</a> vaccine).</p><p>The tech transfer professional’s can-do attitude isn’t a mindset for just this pandemic. For those who stay in this business, this is perennial behavior. While we may enter technology transfer for a variety of reasons, the caring, get-things-done community is one of the reasons the long termers stay. So I’d like to give a huge shout-out to these shepherds of technology — thank you for the long hours, for tackling new territories, for the general make-it-happen mindset that we know you always have, but is especially shining through right now.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4ab69140ce7e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/why-work-in-tech-transfer-the-pandemic-has-illustrated-why-people-do-4ab69140ce7e">Why work in tech transfer? The pandemic has illustrated why people do.</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Beware of employee equity, the credit cards of the venture community]]></title>
            <link>https://medium.com/osage-university-partners/beware-of-employee-equity-the-credit-cards-of-the-venture-community-985876b3bdc6?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/985876b3bdc6</guid>
            <category><![CDATA[equity-tips]]></category>
            <category><![CDATA[founders]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[cap-table]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Natasha Azar]]></dc:creator>
            <pubDate>Tue, 09 Jun 2020 13:12:20 GMT</pubDate>
            <atom:updated>2020-06-09T13:12:20.860Z</atom:updated>
            <content:encoded><![CDATA[<p>By Dror Futter of Rimon Law &amp; Natasha Azar of OUP</p><p>When hiring venture executives and employees in the early stages of a university start-up, the buzz centers around equity. For successful ventures, these equity rights, often issued when the equity is worth pennies a share, hold the potential of delivering great wealth to those fortunate enough to receive them. However, there is an often ignored drawback to equity compensation — simply stated, it is the credit card of the venture world. As opposed to salaries that directly impact budgets, equity grants are “painless” and only upon exit of the venture does the true cost of the grants become apparent.</p><p>The painlessness of equity grants makes it a very tempting compensation tool for cash-strapped early-stage start-ups. But these ventures often risk making outsize equity grants to employees who, while important in the short term, will not have a significant long-term impact on the company. Many ventures fail to recognize that equity needs to be budgeted and, as a result, “spend” too much too early, leaving less available for additional grants to round out the leadership team and make other critical hires.</p><p>For university spinouts that often need to hire a large part of their future executive teams, mistakes in early equity grants can unnecessarily dilute founders’ and university’s common stock positions.</p><p>To understand the impact of dilution on a founder’s stake, <strong>Figure 1</strong> shows a hypothetical ownership summary that reflects typical ownership through financing rounds and how the dilution plays out. As the figure shows, while the nominal value of the founder’s stock is increasing, even in a successful venture, the founder’s ownership percentage declines steeply as a result of dilution. In the hypothetical, the company has raised a total of $41 million in four funding rounds. Each of the funding rounds represented an “up round” where the pre-money represented a significant increase from the post-money valuation of the prior round. Yet the founders’ share dropped from 30% to 12% — in other words, a smaller piece of a larger pie.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/974/0*h48HBr0Q3X39z4sb.png" /><figcaption><em>Figure 1</em></figcaption></figure><p>The average successful tech start-up exits for $240M after a series of raises totaling approximately $40M of capital. This amount of capital is typical of the industry, and it is distinct from the need to refresh the start-up’s option pool across each financing.</p><p>The purpose of raising capital can be evaluated across three categories that fuel a start-up engine into wild success: 1) value inflection; 2) employee compensation; and 3) growth. Venture investment is a double-edged sword: by accepting investment, a founder loses control and ownership; but without investment that same founder cannot feed the engine that creates value. Driving a start-up through a value inflection point can be achieved through both quantitative and qualitative milestones, but it should be simply thought of as the means by which a $1M investment can create a large valuation uptick in a subsequent fundraising round. In most companies, employee compensation is the largest expense, and certain skillsets and geographies garner surprisingly high salaries. Lastly, fueling growth with investment capital is the tool that allows companies to expand their team, footprint, facilitation, and marketing.</p><p>In the typical funding and exit described in the hypothetical, the founders, founding team, and employees were diluted over time. While 12% of a $240M exit is a definitively life-changing event, the path to even larger personal upside can only be achieved by reducing dilution and increasing valuation.</p><p>The dilution equation is simple ($-raised/$-valuation), but the implications of driving the numerator to $0 or the denominator to unicorn status is much more nuanced. When founders are building their cap tables, they should think about how taking more dilution will ultimately create a bigger pie to take a slice of down the road. For founders and their university tech transfer partners, this dilution can be exacerbated by poor choices in equity grants to employees.</p><h4>Holistic approach to compensation</h4><p>Ideally, employee compensation should address three goals — recruitment, performance and retention. When on-boarding employees, ventures have several economic “levers” at their disposal, each of which serves as a different form of incentive. While the true cost of equity grants is often deferred to exit, ventures should balance these levers to achieve the goals of compensation, while minimizing the size of dilutive equity grants. A company’s primary levers are:</p><ul><li>Base Compensation — Start-ups typically can pay less than their established peers because of the equity compensation usually provided. However, it is important that this compensation be competitive with other start-ups in the same geography and that it meets the basic “living wage” requirements of recruits.</li><li>Benefits and Perks — This is often where ventures try to distinguish themselves in recruiting. Ping pong tables, beer on tap, gym memberships, etc. are viewed as relatively inexpensive ways for ventures to set themselves apart. However, these benefits can add up to substantial sums of money and are typically the first things eliminated by struggling ventures.</li><li>Bonuses — Less common for early stage companies (except for sales professionals who often work on a partial commission basis), bonuses are very effective in driving employees towards discrete, shorter term goals. It is critical that the basis for the payment of a bonus or commission and the timing of the payment is clearly laid out.</li><li>Equity — Granting equity to employees and other service providers has two main goals. First, it creates long term alignment since all recipients are incentivized to increase the value of the company as a whole rather than meet narrow metrics. Second, since equity is often granted subject to multi-year vesting, it creates a cost for leaving the company which serves as a form of golden handcuffs.</li></ul><h4>A more detailed look at equity</h4><p>Equity grants can take several forms, the most common forms are[1]:</p><ul><li>Stock Options (Incentive Stock Options (ISOs)/Non-Qualified Stock Options (NQOs/NSOs) — Employees are given the option of purchasing common shares of the company upon the payment of an option strike price equal to the fair market value of the stock at the time of grant.</li><li>Restricted Stock Awards — These are actual grants of shares in the company, usually subject to a company repurchase option (reverse vesting) and transfer restrictions. These grants are taxed immediately as income and as a result, they are usually made only when the granting company has minimal value.</li><li>Restricted Stock Units — These units are issued to an employee through a vesting plan after remaining with their employer for a particular length of time. RSUs give an employee an interest in company stock but they have no tangible value until vesting is complete. The value of the stock received at the completion of vesting will be taxed as ordinary income.</li><li>Stock Appreciation Rights — The recipient is not actually given shares. Instead the recipient receives a contractual obligation from the employer to make a payout equal to the value of the appreciation of a specified number of shares upon the occurrence of a specified event or the passage of a specified period of time.</li></ul><p><strong><em>(Editor’s note: For a chart that describes each form of equity grant in greater detail, please go to </em></strong><a href="https://rimonlaw.com/employee-equity"><strong><em>https://rimonlaw.com/employee-equity</em></strong></a><strong><em>.)</em></strong></p><p>Options are the most common form of incentive for venture-backed companies. However, when company valuations are still low, restricted stock awards offer certain tax advantages. Restricted Stock Units tend to be granted more frequently by later stage companies. There are several concepts that apply to all equity grants:</p><ul><li>Tax “Clock”. When it comes to equity grants, founders should be aware that they are working under a ticking tax clock. Assuming the company increases in value, its share price is increasing as well. This impacts both stock and option grants. If stock is granted to an employee, it must be reported as compensation to the employee. As a result, the employee will have an immediate tax liability upon receipt for the fair market value of the stock. The exercise price of a stock option has to be set at the then current fair market value of the stock or it may be considered deferred compensation under Section 409(a) of the tax code.[2] Assuming the company is increasing in value, the longer a company waits to grant an employee option, the higher that tax will be for stock grants and the higher the strike price will be for options. Companies also have to be careful that stock/options are valued on the date the grants are actually completed. It is not uncommon for companies to delay formally documenting grants, and backdating grants can have legal consequences.</li><li>Vesting. To achieve the goal of promoting employee retention, equity grants are usually subject to vesting. Vesting is implemented in different ways for stock grants and options, but the goal is the same — at the point where vesting ends, an employee leaving the company before the end of the vesting period will generally suffer an adverse consequence with respect to the unvested portion of the equity/options. Under certain circumstances, the adverse consequence is extended to vested shares.</li></ul><p>Although there is no legally required vesting structure, the most common vesting structure is known as “4 years with a 1 year cliff.” Under this structure, the shares remain unvested until the first anniversary, when 25% vests. The remaining 75% vests in equal monthly installments over the following three years. In situations where the employee has already worked a significant period of time before the grant of equity/options, a portion of the grant may be fully vested immediately.</p><h4>Budgeting your equity grants</h4><p>So, how should a university start-up allocate equity across its founders? <strong>Figure 2</strong> shows a breakdown of the typical initial founder’s split in a physical sciences company. <strong>Figure 3</strong> provides a more detailed breakdown of typical pre-financing equity compensation per employee level for a university spinout.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/847/0*Ag-8sIFZ64nUj5Ee.png" /><figcaption><em>Figure 4. Data Source: OUP surveyed 20 physical science portfolio companies for insight into a university startups’ early cap table.</em></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/924/0*SQ9H4QBvinQ3ND-1.png" /><figcaption><em>Figure 3. Data Source: OUP surveyed 20 physical science portfolio companies for insight into a university startups’ early cap table.</em></figcaption></figure><p>What is most noteworthy about this chart is the relatively small grants given to employees below the C-Suite level. These ranges should be kept in mind by ventures making grants to early hires. Even if a web designer is critical to the initial success of a venture and is willing to work for below-market wages, the individual has skills that in most cases are easily replaceable in the future. As a result, a grant of even .2% equity may be over-generous and unnecessarily deplete the equity budget.</p><p>On the other hand, the chart makes it clear that not all members of the management team are created equal. In most start-ups with two to four founders, there is often one charismatic leader that should be incentivized with a disproportionate share of equity. This Lead Founder/CEO typically receives the largest chunk of ownership, around 30–60%. If there is no CEO or lead in place, part of this piece would be set aside for a CEO who is brought on later. Co-founders and other key employees such as founding scientists, C-level executives, VPs, and initial employees should share in approximately 40% of equity allocation. The remaining ~20% option pool should be preserved for future hires. At each round of financing, the option pool should be refreshed (dilution!) to 15–20% until a full C-Suite has been hired. Employee options are issued throughout the lifecycle of the company to employees to fight against dilution. It is challenging to maintain employees at a high equity level throughout the course of a start-up, as there are few instances where you can significantly top off an employee’s equity piece.</p><p>The Founding CEO is someone who intends to stay with the company over the long haul, carrying it from launch to exit. An Active Founding Scientist can be a principal investigator or graduate researcher who has developed the technology at a university, or a PI who bucks the norm and commits to taking leave from the university for two to three years. The Active Founding Scientist commonly assumes the role of CSO and CTO and leaves university for at least one year on sabbatical to work for the start-up full-time.</p><p>By contrast, a Passive Founding Scientist may only be involved once a week or once a quarter with the company. Very rarely, the Active Founding Scientist has the temperament and bandwidth to run as a founding/first/interim CEO, and should be rewarded with equity akin to Founding CEO. Despite their life’s work being a part of the start-up’s mission, most faculty fall into the category of Passive Founding Scientists, which typically should only be rewarded with 1–5% equity to create a clean cap table.</p><p>What is the value in having a founding scientist on the team and on the cap table, especially if his/her involvement would be limited? Once the founding scientists return to the university, their time is best spent on strategic efforts like hiring, R&amp;D, or broad business relationships; assigning an operational role to a part-time employee would be unrealistic. Keeping a founding scientist on the cap table not only allows access to new developments in that lab in the related space, but more importantly to a pipeline of students from the lab. In addition, founding scientists often have high research connections with major companies that will trigger research collaborations and/or commercial agreements for the start-up. An affiliation with the university and high-profile researcher can help the company with fundraising and customers as well.</p><h4>Not one-size-fits-all</h4><p>Start-up compensation is not a one-size-fits-all proposition. It depends on many factors such as the financial situation of the venture and its future financing needs, the market for talent in which it competes, and the prospects — real or perceived — of the venture. What founders and other holders of common shares, such as universities [via their TTOs], need to keep in mind is that similar to credit card debt, poor use of equity has a cost — most of it borne by the common shareholders. Ventures should use all compensation tools at their disposal that create the right balance of incentives and current versus future costs.</p><p><strong>Co-authored by:</strong></p><p><strong>Dror Futter<br></strong><em>Partner</em><br><em>Rimon Law</em></p><p><strong>By Natasha Azar<br></strong><em>Senior Manager of University Relations</em><br><em>Osage University Partners</em></p><h4><strong>Footnotes</strong></h4><p>[1] All the forms of equity grants described are relevant to corporations. However, there are counterpart, largely equivalent grants for companies set up as limited liability companies.</p><p>[2] All but the earliest stage ventures should seek third party valuations (often called “409A Opinions”) to support their determinations of the fair market value of the stock.</p><h4>Acknowledgements</h4><p><em>The authors wish to thank Manny Stockman and John Lee of OUP for their help and expertise on sections of this article that pertain to equity budgets and appropriate equity allocation for early stage university startup companies. Contact Futter at </em><a href="/service/mailto:dror.futter@rimonlaw.com"><em>dror.futter@rimonlaw.com</em></a><em>; contact Azar at </em><a href="/service/mailto:nazar@oup.vc"><em>nazar@oup.vc</em></a><em>.</em></p><p><a href="https://techtransfercentral.com/reprints/ttt/1019-beware-of-employee-equity-the-credit-cards-of-the-venture-community/"><em>This article</em></a><em> appeared in the </em><strong><em>October 2019</em></strong><em> issue of </em><strong><em>Technology Transfer Tactics</em></strong><em>. </em><a href="https://techtransfercentral.com/marketplace/ttt/sample/"><strong><em>Click here</em></strong></a><em> for a free sample issue or </em><a href="https://techtransfercentral.com/marketplace/ttt/subscribe/"><strong><em>click here</em></strong></a><em> to subscribe.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=985876b3bdc6" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/beware-of-employee-equity-the-credit-cards-of-the-venture-community-985876b3bdc6">Beware of employee equity, the credit cards of the venture community</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[An Interview with Nancy Sullivan, CEO & Managing Director of Illinois Ventures]]></title>
            <link>https://medium.com/osage-university-partners/an-interview-with-nancy-sullivan-ceo-managing-director-of-illinois-ventures-799ab8e956c2?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/799ab8e956c2</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[vc]]></category>
            <category><![CDATA[illinois]]></category>
            <category><![CDATA[university]]></category>
            <dc:creator><![CDATA[Kirsten Leute]]></dc:creator>
            <pubDate>Fri, 21 Sep 2018 13:28:56 GMT</pubDate>
            <atom:updated>2018-09-21T13:28:56.000Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*s7oZrmvnh5bE9jM4yo_mQA.jpeg" /><figcaption>Nancy Sullivan</figcaption></figure><p>In June, OUP released our Research Realized interview with Nancy Sullivan, CEO and Managing Director of <a href="http://illinoisventures.com/">Illinois Ventures</a>. Illinois Ventures is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences, and life sciences.</p><p>While their origins are investing in businesses based on innovations from the University of Illinois, they have also expanded to explore other regional opportunities. Illinois Ventures offer three types of funding: proof of concept grants, seed funding, and venture capital.</p><p>Most universities I know are now employing some sort of internal proof-of-concept grants — but to combine those with seed funding and venture capital under one roof is a fairly unique concept. The proof-of-concept funding is Illinois Ventures’ newest area of funding, with $50,000 for a first phase and possibly a larger amount in a second phase if the first phase goes well.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-e6LDfzc9EplhYk7aZQAKg.png" /></figure><p>For their seed stage funding, Illinois Ventures typically invests around $150,000 in a $500,000 round, usually through a convertible note. Illinois Ventures recently announced the raise of their third venture fund and have already started investing out of it.</p><p>Nancy and I explored a range of topics during the interview, from the work done at Illinois Ventures, to attracting talent to Illinois startups, to her work at the Women’s Entrepreneurial Life Sciences Initiative. Excerpts of the interview are below, but you can find the full interview on <a href="https://soundcloud.com/researchrealized/">SoundCloud</a> or <a href="https://itunes.apple.com/us/podcast/research-realized/id1330708846">iTunes</a>.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fw.soundcloud.com%2Fplayer%2F%3Furl%3Dhttps%253A%252F%252Fapi.soundcloud.com%252Ftracks%252F460460868%26show_artwork%3Dtrue&amp;url=https%3A%2F%2Fsoundcloud.com%2Fresearchrealized%2Fa-conversation-with-nancy-sullivan-ceo-of-illinois-ventures&amp;image=http%3A%2F%2Fi1.sndcdn.com%2Fartworks-000362626215-5ltd5m-t500x500.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=soundcloud" width="800" height="166" frameborder="0" scrolling="no"><a href="https://medium.com/media/2e6e38645410e22eb302c4b977348044/href">https://medium.com/media/2e6e38645410e22eb302c4b977348044/href</a></iframe><h4>For those considering university venture funds, what helps make a successful fund?</h4><blockquote><em>If you’re investing in university-related technologies and you’re at the very front end of these [financings], these are typically not going to be me-too products. These are revolutionary, trailblazing products that are going to make very large impacts. But in order to do so, you have deep technology risks that you are going to have to get over, you then have to get over some market risks and adoption because it is a change, and then you are looking at an execution risk.</em></blockquote><blockquote><em>So, those risks are very real, but the opportunity is transformational, and as you think about it, you need to try and keep it in the lab as long as possible to reduce some of that technology risk where you can and focus more on the execution and the market risk once you do a startup. We have a lot to do at the university with resources on the technology side. We want to support our researchers after the federal grants run out because this is too late for [federal grants], but may not be ready for a startup … so I think that models that have done [this further support] are smart…</em></blockquote><blockquote><em>It also gives a faculty member a feel for what it might like to do a startup because you’ve defined the milestones, you’ve defined the timeline, you’ve defined what has to come out, it’s go/no-go; it starts feeling a little different than a typical federally-funded research grant. It allows the faculty member to understand if they feel right doing that or not.</em></blockquote><blockquote><em>The second thing… is that you can’t do it alone. This is not a singles game by any means… We want large co-investment networks around the table. We’d be happy to share the upside, but often it takes a lot of time, a lot of expertise, and a lot of money, and the more you can have at the beginning, the easier that process is to the growing pains [of the startup.]</em></blockquote><h4>Attracting talent to Illinois startups:</h4><blockquote><em>For the talent that has moved to the west coast, it was enticing when they got right out of college, sharing a studio with four buddies, being in Silicon Valley, but after they get married, perhaps, have their first child, coming home, being close to the grandparents, and being able to afford a nice home in the area, has been a way… to attract the talent that is experienced to come back. What we have to show them … is that if you take a risk and you join a startup and that doesn’t work, there are three or four more waiting for you to join.</em></blockquote><h4>Describing the changes to the Illinois University startup scene:</h4><blockquote><em>In Champaign, we have a nationally-recognized incubator called </em><a href="http://researchpark.illinois.edu/enterpriseworks"><em>EnterpriseWorks</em></a><em> and a research park that is starting to attract some of the larger marquis-name companies… Here in Chicago, we have an amazing medical school, and alongside our medical school we’ve seen the opening of something called </em><a href="https://matter.health/"><em>Matter</em></a><em>. It’s an incubator focused in the healthcare area [located] in downtown Chicago that is three years old now and is at a point that it is attracting international attention.</em></blockquote><blockquote><em>IT has been an area of growth for Chicago. </em><a href="https://1871.com/"><em>1871</em></a><em> was launched as an incubator. The university is a partner in both Matter and 1871 to try and take ideas out of the lab, into the startup community, and get them involved in incubation and programs that make a big impact. In all of those, one of the key pieces we’ve seen that have made strong roads for us is our corporations [and venture capital colleagues] are getting involved early on [to help] advance them.</em></blockquote><h4>· While working at Northwestern, Nancy began the Women’s Entrepreneurial Life Sciences Initiative. Here are some takeaways from that experience.</h4><blockquote><em>At the time [at Northwestern] we had a Vice President for Research, Dr. Lydia Villa-Komoroff, who was very supportive of women and very supportive of the idea [I had]. I was complaining that we weren’t seeing a whole lot of women-led ideas. She looked back at me and said, “What are you going to do about it?” …</em></blockquote><blockquote><em>I found [an NSF grant program] and I brought it to her. I am not a PhD. I did not realize what the NSF requires, and she looked at me and said yes, and I’ll be your co-PI. It wasn’t until years later that I realized what she had done for me. What I learned from that experience … is what you need to do for others, and how you can do it quietly without ever having to explain what you’ve just done. People will realize it one day. That’s a lesson for me personally.</em></blockquote><blockquote><em>On a professional front, I really realized that the ideas women had were amazing. Their opportunities were incredibly real. I think we’ve gotten over this as this was years ago, but at the time how the story was being told [by women] was quite different than what the funding world was used to. It wasn’t the base technology, it wasn’t the ideas. [We spent] a lot of time with the women helping them rethink and be very clear and confident in what they had… It was going from being a scientist to [a marketer] and getting these ideas forward. We ended up having lab space where they could do those killer critical experiments — don’t go out and raise money too early. People don’t want to hear what you think can happen. Go in the lab, spend three months, and see if you can make it happen. Once you make it happen, let’s raise the money at that time.</em></blockquote><p>Nancy had a number of other great insights on both university venture capital and mentoring women scientists. Listen to the full Research Realized interview on <a href="https://soundcloud.com/researchrealized">Soundcloud</a> or <a href="https://itunes.apple.com/us/podcast/research-realized/id1330708846">iTunes</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=799ab8e956c2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/an-interview-with-nancy-sullivan-ceo-managing-director-of-illinois-ventures-799ab8e956c2">An Interview with Nancy Sullivan, CEO &amp; Managing Director of Illinois Ventures</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[2018 VC & University Startup Financing Trends]]></title>
            <link>https://medium.com/osage-university-partners/2018-vc-university-startup-financing-trends-5e61afa04697?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/5e61afa04697</guid>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[university]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[financing]]></category>
            <dc:creator><![CDATA[Natasha Azar]]></dc:creator>
            <pubDate>Tue, 03 Jul 2018 14:07:38 GMT</pubDate>
            <atom:updated>2018-07-31T12:42:07.408Z</atom:updated>
            <content:encoded><![CDATA[<p>We’re almost halfway through 2018, which means we at <a href="http://osagepartners.com/osage-university-partners/">Osage University Partners</a> (OUP) again hosted our annual financing trends webinar (<a href="https://medium.com/osage-university-partners/whats-the-pulse-on-2017-midyear-vc-investment-e16d29f4642e">last year’s recap</a>). For the 2018 version, our investment team analyzed not only general VC investment trends, but also trends specific to our partner university network of 5,000+ startups.</p><p>I should mention this blog post only pulls a few highlights out of the webinar. For a more thorough analysis of the current state of startup funding, I encourage you to watch or listen to the <a href="https://www.youtube.com/watch?v=_OkD3PAfaE0&amp;t=417s">full webinar</a>.</p><p>So which sectors have had the greatest investment and which are facing funding challenges? How do these trends apply to advancing academic technologies? What does the beginning of 2018 imply for the rest of the year and what lies over the horizon?</p><h4><strong>VC Activity Overall</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/605/1*umU8yx-Ehi8Lt_S1vdM2yg.png" /><figcaption>Source: Pitchbook NVCA 2017 report</figcaption></figure><ul><li>In 2017, VCs invested the most capital since the dot-com era: $84B. That is a 16% increase over the prior year. At the same time, there has been a decrease in the overall number of deals since 2015, and a consolidation of VC dollars towards a few perceived winners.</li></ul><h4>VC First Financings</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/605/1*I31mQeM0vImMtMcLLVrlmg.png" /><figcaption>Source: Pitchbook NVCA 2017 report</figcaption></figure><ul><li>The number of first financings has been steadily declining since 2014.</li><li>The median age of companies raising angel &amp; seed rounds has risen from 1.6 years to 2.4 years — a 34% jump since 2013.</li></ul><h4>Software</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zpGN7rYZg1C4g6UFfakzgg.png" /><figcaption>Source: 2017 NVCA/PB Report</figcaption></figure><ul><li>Software has taken a slow downturn in both share of total US VC funding in dollars and deal count, down from 47% in 2016 to 36.5% in 2017. This slight funding dip has mostly impacted early stage financings, where deal volume is nearly half its peak in 2014.</li><li>That said, all stages of software deal activity have been shrinking since 2014, not just early stage financings. This is partly a result of VCs becoming more disciplined on funding, and substantial dollars going into a few select players via megafunds and ICOs.</li><li><em>Emerging areas:</em> AI Optimized Computing, AI Applications, Next Generation Encryptions, Serverless and Function as a Service, Bioinformatics, Enterprise Blockchain.</li><li><em>Less Active:</em> Apps, SaaS, and Fintech.</li></ul><p><strong>Early Stage Software</strong></p><ul><li>In the past, software seed financings were characteristically $500K and Series A rounds ranged from $2–10M. In recent years we have seen a shift to larger seed investments that resemble a Series A round, and a new financing class has emerged called the ‘pre-seed,’ filling the seed round void.</li><li>There has been a dramatic decrease in (what we are referring to as) ‘Pre-Seed’ financings since 2015, with angels having exited and traditional seed investors moving on to larger financings.</li><li>Investors focusing on ‘pre-seed’ rounds are often accelerators, some of which are tied to strategic and corporate venture capital, and others to university ecosystems.</li></ul><h4><strong>Physical Sciences</strong><a href="#_ftn1"><strong>[1]</strong></a></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/441/1*nVkUyUPRNbh9ZuMu1BodoA.png" /><figcaption>Source: OUP Database, Datafox, Pitchbook. Data includes OUP partner institution startups only.</figcaption></figure><ul><li>Investment in hardware has been growing as VC attention returns to general core technologies, although cleantech and materials investing continues to be small (and volatile).</li><li>There has been an uptick of VC investment in hardware over the past several years, with a very rough approximation evidencing that university startups are responsible for almost 10% of hardware venture activity. This strong growth has been fueled by a few consumer plays and huge growth in the semiconductor space.</li><li>Still, 3x more dollars are being invested in software than hardware.</li><li><em>Emerging areas</em>: Autonomous Driving, AI Chips, Quantum Computing, Robotics, Industrial IoT.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*iXTed8I2w3NdtE-ePsDbDQ.png" /><figcaption>Source: Datafox, Pitchbook</figcaption></figure><p><strong>Deep Dive: Chips for AI and the Edge</strong></p><ul><li>Leaders like Google and Apple are building their own datacenter/edge chips for AI algorithms and demonstrating the use case for ASICs in servers.</li><li>Power consumption and on-device capability drive interest for dedicated edge processors that can deploy neural networks efficiently on small devices.</li><li>Some large mega-deals are providing companies with significant runway, but outside of mobile, there is uncertainty where large quantities and large-revenue designs wins will come from.</li></ul><h4><strong>University Tech Startup Activity</strong></h4><ul><li>University startup financing trends are well aligned with overall startup financing trends. While the amount of capital raised by OUP partner university startups<a href="#_ftn1">[2]</a> has been steadily increasing each year, the number of deals funded has been decreasingover the past 5 quarters.</li><li>Tech startup HQs have been gradually expanding to entrepreneurial hubs outside of California showing more geo-diversity.</li></ul><h4><strong>Therapeutics Trends</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/898/1*pTvtAXZSP1-GIP0ZeXPgbw.png" /></figure><ul><li>More than 60 therapeutics-focused venture funds are investing in the early pre-clinical stage (see chart above).</li><li>In 2017, more than $1B was raised by first-time venture funds investing in therapeutics at the company formation and early preclinical stage, implying that there is a healthy appetite amongst Limited Partners (LPs) to fund the creation of new venture capital funds with this strategy. Some of these funds are Bioinnovation Capital, Kairos Ventures, Pivotal Bioventure Partners, Quark Ventures, Arix Bioscience, Vide Ventures, and Samsara BioCapital.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/962/1*uHyCDeFmOyMf4b37hPIe1g.png" /><figcaption>Source: OUP Internal Data, Datafox. *Does not include IPOs or post IPO transactions. ^Likely below actual as some 1Q2018 financings have not yet been publicly reported.</figcaption></figure><ul><li>In 2017, there were 167 private biotech financings in start-ups from OUP partner institutions, raising ~$3.5B</li><li>Since 2015, the ratio of the capital raised to number of deals among OUP partner institution startups continues to reflect the trend towards large mega-round financings in biotech. In 2015, our partner institution biotech startups raised $3.6B across 184 deals, $3.3B across 191 deals in 2016, and $3.5B across 167 deals in 2017.</li><li>For financings larger than $1M, the median round size was $14M.</li><li><em>Emerging (and Continuing) Trends</em>: Immuno-oncology, Oncology, Immunology / autoimmune / NASH, CNS, Novel Targets &amp; Platforms, Orphan / Rare Diseases, Gene Therapy.</li></ul><h4><strong>Medical Device Trends</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/553/1*fg2kdS_yixebMt9mcxOKhA.png" /><figcaption>Source: <em>SVB 2018 Healthcare Report</em></figcaption></figure><ul><li>The number of medical device deals remained steady in 2017, however the total capital invested in the medical device sector increased by almost 40%.<strong> </strong>This was primarily driven by an increase in Series A funding and increased investment interest from corporate VCs.</li><li>In the device sector overall, cardiovascular devices captured the most investment dollars ($451M), followed by Neuro ($276M), and Ear, Nose and Throat ($235M).</li><li>IPO &amp; M&amp;A volume matched that of 2016 but is still down from the peak seen in 2015.</li><li>In 2016, family offices and PE funds showed increased activity in medical device investing. That interest continued into 2017, but the sector also saw signs of renewed interest from traditional VCs such as HealthQuest, Novo, and OrbiMed.</li></ul><h4><strong>Diagnostics Trends</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/528/1*mGN7793VvUANytEJ89DHnQ.png" /><figcaption>Source: <em>SVB 2018 Healthcare Report</em></figcaption></figure><ul><li>Diagnostics &amp; tools fundraising increased 40% in 2017, reaching $2.8B. This was in part driven by mega-investments in Guardant Health and Grail ($1.6B in total).</li><li>The number of Series A investments increased by 30% from 2016–17, though the total Series A investment dollars in 2017 remained relatively flat in comparison to 2016.</li><li>The exit landscape has been bleak, with only one diagnostic IPO in 2017, and not a single acquisition.</li><li>Exits in diagnostics &amp; tools have been archetypally dominated by players such as Roche and Illumina, though there is an expectation that new tech acquirers will be invading the healthcare space such as Amazon, Apple, and Alphabet.</li><li>Speaking of invading tech investors, since 2015 traditionally tech-focused VCs have emerged as active investors in the diagnostics &amp; tools sector. The new investors include well-known tech VCs such as Data Collective, Khosla, and Sequoia.</li></ul><p>It’s unclear whether 2018 will surpass 2017’s record high $84.2B VC investment, nor whether VC dollars will continue to consolidate towards perceived winners thus shrinking the number of startups getting funded. We’ll be back at the end of the year with an update on university startup financing trends. In the meantime, check out our <a href="https://www.youtube.com/channel/UCt-Ih-PDZYEiguh_pIevDaA/videos?view_as=subscriber">webinar archive</a> on various industry sector startup and financing trends.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F_OkD3PAfaE0%3Fstart%3D1829%26feature%3Doembed%26start%3D1829&amp;url=http%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D_OkD3PAfaE0&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F_OkD3PAfaE0%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="854" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/5a6af0ca7588d3d5bc304646fe2862ed/href">https://medium.com/media/5a6af0ca7588d3d5bc304646fe2862ed/href</a></iframe><p><em>Notes</em></p><p><a href="#_ftnref1">[1]</a> ‘<a href="http://osagepartners.com/osage-university-partners/university-partners/">Partner university</a>’ refers to the 97 institutional technology transfer offices (TTOs) OUP has a relationship with.</p><p><a href="#_ftnref1">[2]</a> We interpret physical sciences as hardware, materials, and cleantech.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5e61afa04697" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/2018-vc-university-startup-financing-trends-5e61afa04697">2018 VC &amp; University Startup Financing Trends</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[An interview with Lita Nelsen and Katharine Ku]]></title>
            <link>https://medium.com/osage-university-partners/an-interview-with-lita-nelsen-and-katharine-ku-ac16cdbd1c27?source=rss----a86acede77e---4</link>
            <guid isPermaLink="false">https://medium.com/p/ac16cdbd1c27</guid>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[stanford]]></category>
            <category><![CDATA[mit]]></category>
            <category><![CDATA[podcast]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Kirsten Leute]]></dc:creator>
            <pubDate>Wed, 06 Jun 2018 23:53:31 GMT</pubDate>
            <atom:updated>2018-06-07T14:47:28.670Z</atom:updated>
            <content:encoded><![CDATA[<iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fw.soundcloud.com%2Fplayer%2F%3Furl%3Dhttp%253A%252F%252Fapi.soundcloud.com%252Ftracks%252F371920733%26show_artwork%3Dtrue&amp;url=https%3A%2F%2Fsoundcloud.com%2Fresearchrealized%2Fa-conversation-with-katharine-ku-lita-nelsen&amp;image=http%3A%2F%2Fi1.sndcdn.com%2Fartworks-000272286065-sg5r6m-t500x500.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=soundcloud" width="800" height="166" frameborder="0" scrolling="no"><a href="https://medium.com/media/7cee6504d8be4cdbc28198b76d80f491/href">https://medium.com/media/7cee6504d8be4cdbc28198b76d80f491/href</a></iframe><p>Some people had the fortune to fall into technology transfer before it was a known career and helped shape the field to become the vibrant, challenging, and rewarding profession it is today. Two of those players are Lita Nelsen, former Director of MIT’s Technology Licensing Office, and Katharine Ku, former Executive Director of the Office of Technology Licensing of Stanford University who retired from Stanford on June 1st. I had the pleasure of <a href="https://soundcloud.com/researchrealized/a-conversation-with-katharine-ku-lita-nelsen">interviewing Lita and Kathy</a> this past fall as part of our new podcast, <a href="https://soundcloud.com/researchrealized">Research Realized</a>. During our conversation, we talked about the past and future of technology transfer, including their advice for future leaders in the field.</p><p>Kathy and Lita both spent decades in their positions at their respective institutions. Before their technology transfer careers began, Kathy and Lita were self-described job-hoppers. However, the work at Stanford and MIT remained so fulfilling over the years that neither Kathy nor Lita had a desire to leave the field of technology transfer.</p><p>We hope you find the following snippets just as captivating as Kathy and Lita found their careers. If you want to learn more, including their thoughts on what they’ve learned from one other, working with their respective administrations, and gap funds, you can listen to the interview on either <a href="https://soundcloud.com/researchrealized">SoundCloud</a> or <a href="https://itunes.apple.com/us/podcast/research-realized/id1330708846?mt=2">iTunes</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/560/1*04CdOq8V-HIFFptaAb1RgA.png" /><figcaption>From left to right: Katharine Ku, Former Executive Director of Stanford’s Office of Technology Licensing; Lita Nelson, Former Director at MIT Technology Licensing Office</figcaption></figure><p><em>On Stanford and MIT’s different philosophies on marketing of inventions:</em></p><p><strong>Kathy:</strong> At Stanford… [our philosophy is] that we need to make our technologies broadly available and that marketing is also a way to mitigate conflict of interest… We do spend a lot of time and resources to try and market our inventions… At the end of the day, I think Lita would say we end up in the same place.</p><p><strong>Lita:</strong> Yes, we end up in the same place. I agree that…to avoid conflicts of interest the efforts to market may be valuable. We didn’t do it simply because from an actual work point of view, [it did not result in] more licenses… Stanford’s view, and you can certainly understand it, was that everybody ought to have a chance to license this technology before we let the inventors do a startup. Our view was that inventors … are absolutely critical to successful exploitation of [early stage technologies] so you might as well skip the step in between. I think you could argue either one.</p><p><em>What roles their offices play with startups:</em></p><p><strong>Lita:</strong> There has been a change over time. Thirty years ago… [our office] would basically act as coaches and mentors to the startups… Over time, there are now [non-technology transfer organizations across campus that focus on startups] as their major mission and put a lot more emphasis into it so … that role [is] not as critical [for our technology transfer office] as it used to be and we can concentrate more on intellectual property and solving the usual messes on getting a new invention off the ground.</p><p><strong>Kathy:</strong> At Stanford… we enable startups, but we do not do a lot to help create them… We’ve never helped with the business plan, etc. In the early years, sometimes the inventors or the startup crew might want some introductions to venture capitalists, but that has really changed lately. Our view is that they need to go find their own money, and they can. There are plenty of resources on campus and in our ecosystem. I often say if [the researchers] just go talk to three people, somebody will be able to help them. It’s a very vibrant ecosystem these days.</p><p><em>On building your network and technology transfer career:</em></p><p><strong>Kathy:</strong> AUTM… is a very welcoming place. People are looking for friendships in the community. Even now, everyone goes to these meetings and they share stories and they realize they are not in a vacuum at all. All the people in the world now, we can share this common experience of working in the university… As you connect with people, keep up the relationship… Learn to get outside input.</p><p><em>What they will miss most being the directors of their respective technology transfer offices:</em></p><p><strong>Lita:</strong> I miss the people, I miss the staff… We were more than colleagues, we were friends.</p><p><strong>Kathy:</strong> I agree. I love coming into work. I love the people I work with. I love, interestingly enough, the fun and challenge of a new issue every single day. Every day I come into work I wonder what will happen that day. But I’ll miss that the least, too!</p><p><em>Advice for the future leaders of technology transfer:</em></p><p><strong>Lita:</strong> Try to teach your bosses, your [administration] that it is not about the money… They have to look at it for all of the other benefits — locally, … it is teaching students and faculty … how to develop technology; regionally, [the benefits are] in terms of economic development; and national and internationally in terms of the impact of the new drugs, the new technology that can help the world.</p><p><strong>Kathy:</strong> Absolutely do the best you can with the cards you’ve been given… Sometimes people get discouraged by patent expenses or making filing decisions or whatever it is that comes up every day… If you continue to do the best for technology transfer and getting the technology out there, that will be true leadership.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*f6-E6ZiSMpbSZ3laVfybcA.png" /></figure><p><strong>A heap of thanks to Lita and Kathy for taking the time for this interview and sharing their wisdom on the field of university technology transfer. If you have thoughts on who you would like to hear on </strong><a href="https://soundcloud.com/researchrealized"><strong>Research Realized</strong></a><strong>, please contact me at </strong><a href="/service/mailto:kleute@osagepartners.com"><strong>kleute@osagepartners.com</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ac16cdbd1c27" width="1" height="1" alt=""><hr><p><a href="https://medium.com/osage-university-partners/an-interview-with-lita-nelsen-and-katharine-ku-ac16cdbd1c27">An interview with Lita Nelsen and Katharine Ku</a> was originally published in <a href="https://medium.com/osage-university-partners">Osage University Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>